Motor Neuron Disease

Motor neuron diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy are progressive neurodegenerative diseases that result in the death of motor neurons. Discover the latest research on motor neuron disease here.

January 21, 2022
Open Access

MRI Volumetric Analysis of the Thalamus and Hypothalamus in Amyotrophic Lateral Sclerosis.

Frontiers in Aging Neuroscience
Shan YeDongsheng Fan
January 21, 2022
Case Report

Total knee replacement in a polio patient with prior extension osteotomy: a case report.

Journal of Surgical Case Reports
Khalid A AlsheikhAli A Alhandi
January 21, 2022

Revealing the Mutational Spectrum in Southern Africans With Amyotrophic Lateral Sclerosis.

Neurology. Genetics
Melissa NelJeannine M Heckmann
January 21, 2022

Body mass index in type 2 spinal muscular atrophy: a longitudinal study.

European Journal of Pediatrics
Gloria FerrantiniItalian ISMAC study group
January 21, 2022

Altered Blood-Brain Barrier and Blood-Spinal Cord Barrier Dynamics in Amyotrophic Lateral Sclerosis: Impact on Medication Efficacy and Safety.

British Journal of Pharmacology
Yijun Pan, Joseph A Nicolazzo
January 21, 2022

High incidence of amyotrophic lateral sclerosis in the Faroe Islands 2010-2020.

Annals of Clinical and Translational Neurology
Malan JohansenMaria Skaalum Petersen
January 21, 2022

Passive immunization against phosphorylated tau improves features of Huntington's disease pathology.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Melanie AlpaughFrancesca Cicchetti
January 21, 2022

Carving the senescent phenotype by the chemical reactivity of catecholamines: An integrative review.

Ageing Research Reviews
Aleksei G Golubev
January 20, 2022
Open Access

Selective inhibition of goal-directed actions in the mesencephalic locomotor region

BioRxiv : the Preprint Server for Biology
N. K. GutJuan Mena-Segovia
January 20, 2022
Open Access

Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1.

Genome Medicine
Restuadi RestuadiFleur C Garton
January 20, 2022

Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2.

Proceedings of the National Academy of Sciences of the United States of America
Radhakrishnan KanagarajStephen C West
January 20, 2022

Regulation of Neurodegeneration-associated Protein Fragments by the N-degron Pathways.

Neurotoxicity Research
Mohamed A EldeebRichard P Fahlman
January 20, 2022

The Gpx4NIKO Mouse Is a Versatile Model for Testing Interventions Targeting Ferroptotic Cell Death of Spinal Motor Neurons.

Neurotoxicity Research
Robert Cole EvansQitao Ran
January 20, 2022

Targeted gene silencing in the nervous system with CRISPR-Cas13.

Science Advances
Jackson E PowellThomas Gaj
January 20, 2022

Mutation in senataxin alters the mechanism of R-loop resolution in amyotrophic lateral sclerosis 4.

Brain : a Journal of Neurology
Annapoorna KannanLaxman Gangwani
January 20, 2022

Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis.

Sai ZhangMichael P Snyder

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved